免疫吸附作为在COVID-19大流行期间抗体捐赠的方法
Jannik Rothenburg1,2, Silke Rink-Baron3, Lisa Müller4
1Institute for Transplant Diagnostics and Cell Therapeutics, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
Vox sanguinis
|May 13, 2024
概括
免疫吸附和触流过有效地将SARS-CoV-2抗体从康复期血中缩起来. 这种方法产生适合潜在的针对SARS-CoV-2的被动免疫策略的高滴度抗体缩物.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 病毒学 病毒学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 感染需要有效的治疗干预措施.
- 康复性血疗法,含有抗SARS-CoV-2抗体,是早期治疗策略.
- 高中和抗体标位对于康复期血治疗的有效性至关重要.
研究的目的:
- 为了评估免疫吸附 (IA) 与接触流过 (TFF) 结合用于抗体度生产.
- 证明IA和TFF产生具有高中和能力的抗体度的能力.
- 评估获得潜在治疗用途的缩抗体产品的可行性.
主要方法:
- 10名捐赠者使用特定抗体吸附柱进行了免疫吸附.
- 使用30kDa膜的触流流过方法,化了抗体的度.
- 通过透过的方式,将甘氨酸缓冲剂换成正常盐水.
主要成果:
- 抗体度在8小时内产生,显示总IgG,IgA和IgM水平显著升高.
- 缩物显示出SARS-CoV-2 N和S抗体的度大幅增加,包括S特异性IgG.
- 在大多数缩物中,特定的SARS-CoV-2病毒中和能力增加,这些缩物在微生物学上安全且稳定一年.
结论:
- 免疫吸附接着触流过是生产低容量抗体度的可行方法.
- 这些缩物含有丰富的IgG,IgA,IgM和SARS-CoV-2特异性抗体,没有白蛋白和凝固因子.
- 需要进一步调查,以确定这些抗体度在感染SARS-CoV-2患者的被动免疫中具有治疗功效.
相关概念视频
Active versus Passive Immunity
633
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
633
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Immunoprecipitation
5.4K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.4K


